Healthcare ❯ Pharmaceuticals ❯ Drug Development

Obesity Treatment

MariTide AMG 786 Small Molecule Drugs Zepbound GLP-1 Drugs Orforglipron GLP-1 Inhibitors

Eli Lilly Picks Huntsville for $6 Billion API Plant to Supply Next-Gen Drugs

The move advances onshoring of active ingredients to support orforglipron within Lilly’s $27 billion U.S. buildout.